# Trametinib Treatment for Complicated Vascular Anomalies

> **NCT07072403** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **West China Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Vascular Anomalies

## Interventions

- **DRUG:** Trametinib tablet

## Key facts

- **NCT ID:** NCT07072403
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-07
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07072403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07072403, "Trametinib Treatment for Complicated Vascular Anomalies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07072403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*